ml 7 has been researched along with Acute Brain Injuries in 2 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, JL | 1 |
| Todd, T | 1 |
| Bazan, NG | 1 |
| Belayev, L | 1 |
| Luh, C | 1 |
| Kuhlmann, CR | 1 |
| Ackermann, B | 1 |
| Timaru-Kast, R | 1 |
| Luhmann, HJ | 1 |
| Behl, C | 1 |
| Werner, C | 1 |
| Engelhard, K | 1 |
| Thal, SC | 1 |
2 other studies available for ml 7 and Acute Brain Injuries
| Article | Year |
|---|---|
Inhibition of Myosin light-chain kinase attenuates cerebral edema after traumatic brain injury in postnatal mice.
Topics: Albumins; Animals; Azepines; Behavior, Animal; Blood-Brain Barrier; Brain Edema; Brain Injuries; Col | 2013 |
Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
Topics: Animals; Azepines; Blood-Brain Barrier; Brain Edema; Brain Injuries; Constriction; Disease Models, A | 2010 |